0001225208-20-003954.txt : 20200302 0001225208-20-003954.hdr.sgml : 20200302 20200302204646 ACCESSION NUMBER: 0001225208-20-003954 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200227 FILED AS OF DATE: 20200302 DATE AS OF CHANGE: 20200302 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Manders Matthew G CENTRAL INDEX KEY: 0001480601 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38769 FILM NUMBER: 20679586 MAIL ADDRESS: STREET 1: 1601 CHESTNUT STREET STREET 2: TWO LIBERTY PLACE CITY: PHILADELPHIA STATE: PA ZIP: 19192 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cigna Corp CENTRAL INDEX KEY: 0001739940 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] IRS NUMBER: 824991898 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 BUSINESS PHONE: 8602266000 MAIL ADDRESS: STREET 1: 900 COTTAGE GROVE ROAD CITY: BLOOMFIELD STATE: CT ZIP: 06002 FORMER COMPANY: FORMER CONFORMED NAME: Halfmoon Parent, Inc. DATE OF NAME CHANGE: 20180508 4 1 doc4.xml X0306 4 2020-02-27 0001739940 Cigna Corp CI 0001480601 Manders Matthew G 900 COTTAGE GROVE ROAD BLOOMFIELD CT 06002 1 President, Strategy & Solution Common Stock, $.01 Par Value 2020-02-27 4 F 0 548.0000 185.7600 D 46018.0000 D Common Stock, $.01 Par Value 2020-02-28 4 A 0 6305.0000 0.0000 A 52323.0000 D Common Stock, $.01 Par Value 2020-02-28 4 F 0 2336.0000 179.4100 D 49987.0000 D Common Stock, $.01 Par Value 2020-03-02 4 S 0 3969.0000 182.8500 D 46018.0000 D Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2017-2019 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 14, 2018. By: Jill M. Stadelman, attorney-in-fact 2020-03-02